Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study
JMIR Formative Research · 2025
DOI: 10.2196/63153 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Formative Research, 2025. Verfasst von Edoardo Bianchini und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Parkinson Disease, Wearable Electronic Devices, Walking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Average daily steps (avDS) could be a valuable indicator of real-world ambulation in people with Parkinson disease (PD), and previous studies have reported the validity and reliability of this measure. Nonetheless, no study has considered disease phenotype, stage, and severity when assessing the reliability of consumer wrist-worn devices to estimate daily step count in unsupervised, free-living conditions in PD.
Objective
This study aims to assess and compare the reliability of a consumer wrist-worn smartwatch (Garmin Vivosmart 4) in counting avDS in people with PD in unsupervised, free-living conditions among disease phenotypes, stages, and severity groups.
Methods
A total of 104 people with PD were monitored through Garmin Vivosmart 4 for 5 consecutive days. Total daily steps were recorded and avDS were calculated. Participants were dichotomized into tremor dominant (TD; n=39) or postural instability and gait disorder (PIGD; n=65), presence (n=57) or absence (n=47) of tremor, and mild (n=65) or moderate (n=39) disease severity. Based on the modified Hoehn and Yahr scale (mHY), participants were further dichotomized into earlier (mHY 1‐2; n=68) or intermediate (mHY 2.5‐3; n=36) disease stages. Intraclass correlation coefficient (ICC; 3,k), standard error of measurement (SEM), and minimal detectable change (MDC) were used to evaluate the reliability of avDS for each subgroup. The threshold for acceptability was set at an ICC ≥0.8 with a lower bound of 95% CI ≥0.75. The 2-tailed Student t tests for independent groups and analysis of 83.4% CI overlap were used to compare ICC between each group pair.
Results
Reliability of avDS measured through Garmin Vivosmart 4 for 5 consecutive days in unsupervised, free-living conditions was acceptable in the overall population with an ICC of 0.89 (95% CI 0.85‐0.92), SEM below 10%, and an MDC of 1580 steps per day (27% of criterion). In all investigated subgroups, the reliability of avDS was also acceptable (ICC range 0.84‐0.94). However, ICCs were significantly lower in participants with tremor ( P =.03), with mild severity ( P =.04), and earlier stage ( P =.003). Moreover, SEM was below 10% in participants with PIGD phenotype, without tremor, moderate disease severity, and intermediate disease stage, with an MDC ranging from 1148 to 1687 steps per day (18%‐25% of criterion). Conversely, in participants with TD phenotype, tremor, mild disease severity, and earlier disease stage, SEM was >10% of the criterion and MDC values ranged from 1401 to 2263 steps per day (30%‐33% of the criterion).
Conclusions
In mild-to-moderate PD, avDS measured through a consumer smartwatch in unsupervised, free-living conditions for 5 consecutive days are reliable irrespective of disease phenotype, stage, and severity. However, in individuals with TD phenotype, tremor, mild disease severity, and earlier disease stages, reliability could be lower. These findings could facilitate a broader and informed implementation of avDS as an index of ambulatory activity in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neuroscience, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Rome, Italy.
- AGEIS, Université Grenoble Alpes, Grenoble, France.
- Department of Neurology, Kiel University, Kiel, Germany.
- Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy.
- IRCCS Neuromed Institute, Pozzilli, Italy.
- Institut Universitaire de France, Paris, France.
ORCID-Profile: Edoardo Bianchini, Domiziana Rinaldi, Lanfranco De Carolis, Silvia Galli, Marika Alborghetti, Clint Hansen, Antonio Suppa, Marco Salvetti, Francesco Ernesto Pontieri, Nicolas Vuillerme
Zitieren
APA
Bianchini, E., Rinaldi, D., De Carolis, L., Galli, S., Alborghetti, M., Hansen, C., Suppa, A., Salvetti, M., Pontieri, F. E., & Vuillerme, N. (2025). Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study. JMIR Formative Research. https://doi.org/10.2196/63153
Vancouver
Bianchini E, Rinaldi D, De Carolis L, Galli S, Alborghetti M, Hansen C, et al. Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study. JMIR Formative Research. 2025. doi:10.2196/63153
BibTeX
@article{Bianchini2025,
author = {Bianchini, Edoardo and Rinaldi, Domiziana and De Carolis, Lanfranco and Galli, Silvia and Alborghetti, Marika and Hansen, Clint and Suppa, Antonio and Salvetti, Marco and Pontieri, Francesco Ernesto and Vuillerme, Nicolas},
title = {Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study},
journal = {JMIR Formative Research},
year = {2025},
doi = {10.2196/63153}
}
EUVIMED